MODIFICATION
B -- Liver Toxicity Test Services
- Notice Date
- 8/6/2010
- Notice Type
- Modification/Amendment
- NAICS
- 541711
— Research and Development in Biotechnology
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services, NCTR-50 RM422 HFT-320, Jefferson, Arkansas, 72079, United States
- ZIP Code
- 72079
- Solicitation Number
- 10-223-SOL-00268
- Archive Date
- 8/26/2010
- Point of Contact
- Nicholas E Sartain, Phone: 870-543-7370
- E-Mail Address
-
nick.sartain@fda.hhs.gov
(nick.sartain@fda.hhs.gov)
- Small Business Set-Aside
- Total Small Business
- Description
- Question: What are the specific cystoplasmic enzyme(s) on which the requestor wants release dose response curves? Answer: The enzymes to be analyzed are the ones commonly measured in clinical and preclinical studies to reflect liver toxicity: ALT, ALP, AST, TBL and LDH.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/NCTR/10-223-SOL-00268/listing.html)
- Place of Performance
- Address: Contractor facility, United States
- Record
- SN02231347-W 20100808/100806234812-45e5285f31a3ad0d17c839de79987e95 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |